Zacks.com featured highlights include Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International

For Immediate ReleaseChicago, IL – November 7, 2024 – Stocks in this week’s article are Alibaba Group BABA, Pfizer PFE, Virtu Financial VIRT, Leidos LDOS and Brinker International EAT.5 PEG-Based GARP Stocks to Buy Amid Election-Week VolatilityJust as the presidential election results are unfolding, investors are certain about one particular thing — a probable increase in volatility in the equity space in the course of the week. At the time of publishing this article, Trump's return to the White House has been confirmed although not officially declared yet.Be that as it may, considering the diverse focus and agenda of the parties, conditional to the final/official voting outcome, a number of sectors are bound to see growth compared to others. While there is still time for investors to clearly understand which sectors to put more money in and which sectors to exit, it will be a prudent idea now to follow a hybrid investment strategy to minimize the risk of this external volatility.Here, to find an answer, we resort to the investing track of the Oracle of Omaha, where he has shown a gradual shift from being a pure-play value investor to a GARP (growth at a reasonable price) investor.Several stocks, which have surged significantly in the recent past, show an overwhelming success of this hybrid investing strategy over pure-play value and growth investments. Here, we will discuss the success of five such stocks. These are Alibaba Group, Pfizer, Virtu Financial, Leidos and Brinker International.More on GARPThe GARP theory enables strategic mingling of growth and value-investing principles, which gives us a hybrid strategy by utilizing the best features of both. What GARPers look for is whether or not the stocks are somewhat undervalued and have solid sustainable growth potential (Investopedia).PEG Ratio and GARPGARP investing gives priority to one of the popular value metrics — the price/earnings growth (PEG) ratio. Although it is categorized under value investing, this strategy follows the principles of both growth and value investing.The PEG ratio is defined as: (Price/ Earnings)/Earnings Growth RateIt relates stocks' P/E ratio with their future earnings growth rates.While P/E alone gives an idea of stocks trading at a discount, PEG, by adding the growth element, helps identify stocks with solid future potential.A lower PEG ratio, preferably less than 1, is always better for GARP investors.Say for example, if a stock's P/E ratio is 10 and the expected long-term growth rate is 15%, the company's PEG will come down to 0.66, a ratio indicating both undervaluation and future growth potential.Unfortunately, this ratio is often neglected due to investors' limitations in calculating the future earnings growth rate of a stock.There are some drawbacks to using the PEG ratio, though. It does not consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.Hence, PEG-based investing can be even more rewarding if some other relevant parameters are also taken into consideration.Our PicksHere are five out of the 14 stocks that qualified the screening:Alibaba: It is one of the leading e-commerce giants in China. Over the last few years, the company has transformed itself from being a traditional e-commerce company to a conglomerate that has businesses ranging from logistics and food delivery to cloud computing. Alibaba is benefiting from strong momentum in its international commerce retail business, driven by strength in AliExpress' Choice.BABA can be an impressive value investment pick with its Zacks Rank #1 and a Value Score of A. Apart from a discounted PEG and P/E, the stock has an impressive long-term expected growth rate of 26.5%.You can see the complete list of today's Zacks #1 Rank stocks here.Pfizer: The company has a wide range of drugs and vaccines. Pfizer's Biopharma reporting segment includes three broad therapeutic areas, Primary Care, Specialty Care and Oncology. Pfizer's non-COVID operational revenues are improving fast, driven by its key in-line products like Prevnar, Vyndaqel and Eliquis, new launches, and newly acquired products, including those from Seagen.Pfizer stock can also be an impressive value investment pick with its Zacks Rank #2 and Value Score of A. Apart from a discounted PEG and P/E, PFE has a solid long-term expected growth rate of 10.7%.Virtu Financial: The company is a market-leading financial services firm that leverages cutting-edge technology to provide execution services and data, analytics and connectivity products to its clients and deliver liquidity to the global markets. Virtu Financial provides a wide array of offerings in execution, liquidity sourcing, analytics and broker-neutral, and multi-dealer platforms in workflow technology.VIRT has an impressive growth rate of 23.6% for the next five years. The stock currently has a Value Score of A and carries a Zacks Rank #1.Leidos: It is a global science and technology leader serving the defense, intelligence, civil and health markets. Its core capabilities include providing solutions in the fields of cybersecurity; data analytics; enterprise IT modernization and so on. Leidos' defense solutions continue to witness increased contract wins from the Pentagon and other U.S. allies, which led to a solid backlog of $40.56 billion at the end of September 2024.LDOS stock can be an impressive value investment pick with its Zacks Rank #1 and a Value Score of B. Apart from a discounted PEG and P/E, Leidos also has an impressive long-term expected growth rate of 12.5%.Brinker: The company owns, operates, develops and franchises various restaurants under Chili's Grill & Bar and Maggiano's Little Italy brands. Brinker remains steadfast in its goal to drive traffic and revenues through sales-building initiatives such as a streamlined menu and innovation, improved value proposition, better food presentation, advertising campaigns, kitchen system optimization and introduction of an enhanced service platform.Brinker can also be an impressive value investment pick with its Zacks Rank #1 and a Value Score of B. Apart from a discounted PEG and P/E, the stock also has a solid long-term expected growth rate of 16.4%.You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2365327/5-peg-based-garp-stocks-to-buy-amid-election-week-volatilityDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.Free Today: Profiting from The Future’s Brightest Energy SourceThe demand for electricity is growing exponentially. At the same time, we’re working to reduce our dependence on fossil fuels like oil and natural gas. Nuclear energy is an ideal replacement.Leaders from the US and 21 other countries recently committed to TRIPLING the world’s nuclear energy capacities. This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the action early enough.Our urgent report, Atomic Opportunity: Nuclear Energy's Comeback, explores the key players and technologies driving this opportunity, including 3 standout stocks poised to benefit the most.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE): Free Stock Analysis Report Brinker International, Inc. (EAT): Free Stock Analysis Report Leidos Holdings, Inc. (LDOS): Free Stock Analysis Report Alibaba Group Holding Limited (BABA): Free Stock Analysis Report Virtu Financial, Inc. (VIRT): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks